|
市場調查報告書
疫苗領域的交易分析
Analysis of Deal Making in Vaccines
|
疫苗領域的交易分析 是由出版商PharmaVentures Ltd在2010年11月所出版的。
這份英文市場調查報告書價格從美金3344起跳。
本報告，針對疫苗市場的交易動向，彙整了治療領域別、種類別、開發階段別、產品別等的市場區塊別動向與參與企業的概要，並利用個案研究進行檢證，由下列摘要形式闡述。
第1章 疫苗的簡介
- 概要
- 市場規模與動向
- 疫苗的治療領域
- 未來的疫苗：開發中的產品與技術
- 主要的參與企業
第2章 疫苗相關交易的整體動向
- 與其他領域的比較
- 疫苗相關交易件數
- 疫苗相關交易額
- 各種治療領域的交易額與件數比較
- 金融危機的影響
第3章 交易類型別疫苗交易分析
第4章 開發階段別交易
第5章 領域別交易
第6章 產品別交易
第7章 交易的專利分析
第8章 疫苗相關交易的主要參與企業
第9章 結論
第10章 附錄：個案研究10件
Abstract
This essential new PharmaDeals® report will help you to identify market size
and trends and who your prospective partners are within the area of vaccines
deal making.
The report answers questions like:
- What are the key players from big and small companies doing in this area?
- How are your potential partners and competitors operating?
- Around what therapeutic areas are the vaccines deals being done?
- How does vaccines deal making compare with other areas for deal making?
- In what territories are the deals being done?
- At what stage in the development process are the deals taking place?
The Report is part of the highly acclaimed and popular series on deal making
in major therapy areas, containing case studies on the key deal makers in this
market.
Table of Contents
1. Introduction to vaccines
- 1.1 Overview
- 1.2 Market size and trends
- 1.3 Therapy areas for vaccines
- 1.4 Future vaccines - products and technologies in development
- 1.4.1 Prophylactic vaccines
- 1.4.2 Therapeutic vaccines
- 1.4.3 Supporting technologies
- 1.5 Key players
2. Overall trends in vaccines deals
- 2.1 Comparison with other areas
- 2.2 Total number of vaccines deals
- 2.3 Total value of vaccines deals
- 2.4 Comparison of number versus value of deals across therapy areas
- 2.5 Impact of the ‘credit crunch' ?
3. Analysis of vaccines deals by deal type
- 3.1 Number of deals
- 3.2 Year on year analysis of vaccines deals by deal type
- 3.3 Deal type by value
4. Vaccines deals by stage of development
- 4.1 Number of deals by stage of development
- 4.2 Value of deals by stage of development
5. Vaccines deals by territory
- 5.1 Number of deals by territory
- 5.2 Interest in emerging markets
6. Vaccines deals by product type
- 6.1 Number of deals by product type
- 6.2 Influenza
7. Analysis of royalties in vaccines deals
8. Key players in vaccine deal making
- 8.1 Key partnering/funding organisations
- 8.2 Key originator companies
9. Conclusions
10. Appendix 1
- Vaccine deals - 10 case studies
|
